Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY（2022）
Key words
pneumonia,microbiological outcomes,causative pathogen,clinical,hospital-acquired,ventilator-associated
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined